Trials / Conditions / Secondary Immune Deficiency
Secondary Immune Deficiency
6 registered clinical trials studyying Secondary Immune Deficiency.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Observational Study of Subcutaneous Immunoglobulin (Cutaquig) in Patients With Primary and Secondary Immunodef NCT04354129 | University of Alberta | — |
| Completed | The Effect of Subcutaneous Immunoglobulin Gammanorm on the Distribution of IgG Subclasses and on Immunity of P NCT03369301 | Octapharma | — |
| Completed | Humoral Immunodeficiency With Rituximab and Therapy With Subcutaneous Ig NCT03211065 | Rochester General Hospital | Phase 2 / Phase 3 |
| Completed | Comparison of Multigam IV (5% vs. 10%) in Patients With an Immunodeficiency Secondary to a Hematological Disor NCT03250845 | Universitaire Ziekenhuizen KU Leuven | — |
| Completed | Facilitated Immunoglobulin Administration Registry and Outcomes Study (FIGARO) NCT03054181 | GWT-TUD GmbH | — |
| Completed | Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on Weekly an NCT02711228 | CSL Behring | Phase 4 |